ZELTIQ to Present at Investor Conferences in March 2015
(firmenpresse) - PLEASANTON, CA -- (Marketwired) -- 02/27/15 -- ZELTIQ®, (NASDAQ: ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Patrick F. Williams, Senior Vice President and Chief Financial Officer, is scheduled to present in two investor conferences in March 2015.
27th Annual ROTH Conference
Monday, March 9, 2015
10:30 a.m. PT / 1:30 p.m. ET
Barclays Global Healthcare Conference
Thursday, March 12, 2015
10:15 a.m. ET / 7:15 a.m. PT
Audio webcasts of the Company's presentations will be available by visiting the investor relations section of ZELTIQ's web site at . Replays of the presentations will be available for 90 days.
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.02.2015 - 21:05 Uhr
Sprache: Deutsch
News-ID 374969
Anzahl Zeichen: 0
contact information:
Town:
PLEASANTON, CA
Kategorie:
Personal Care & Fitness
Diese Pressemitteilung wurde bisher 248 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ZELTIQ to Present at Investor Conferences in March 2015"
steht unter der journalistisch-redaktionellen Verantwortung von
ZELTIQ Aesthetics, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
